Schroder Investment Management Group Eye Point Pharmaceuticals, Inc. Transaction History
Schroder Investment Management Group
- $112 Billion
- Q2 2025
A detailed history of Schroder Investment Management Group transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 313,979 shares of EYPT stock, worth $3.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
313,979
Previous 257,985
21.7%
Holding current value
$3.92 Million
Previous $1.4 Million
111.3%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EYPT
# of Institutions
162Shares Held
67.2MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$104 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$84.8 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$84.8 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$57.4 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$53.6 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $425M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...